You might be interested in
Health & Biotech
Health Check: Latest biotech quarterly results are as patchy as the curate’s egg
Health & Biotech
Weed Week: Musk gives the go-ahead for cannabis advertising on Twitter in the US
Health & Biotech
Health & Biotech
Seasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the radio booth for another instalment of The StockDoc Podcast.
In this episode Nigel chats with Oliver Horn, executive director and group chief executive officer of Elixinol Global (ASX:EXL)
Elixinol Global is an Australian-based hemp company focused on researching, developing, marketing and selling Elixinol-branded, hemp-derived full and broad spectrum CBD products.
The company was covered by Stockhead in early September as it began its bounce back from a sector-wide crash.
So tune in below to hear about what lies ahead for Elixinol Global and the volatile cannabis market.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The StockDoc Podcast with Dr Nigel Finch and subscribe!